MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
OraSure Technologies Interest Expense 2011-2026 | OSUR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense OraSure Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -380 K | 17.8 M | 3.45 M | 872 K | 1.65 M | 2.72 M | 3.29 M | 794 K | 58 K | 774 K | 531 K | 200 K | 172 K | 316 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.8 M | -380 K | 2.31 M |
Quarterly Interest Expense OraSure Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 154 K | - | -21 K | - | 95 K | -43 K | 271 K | - | 2.61 M | 1.47 M | 2.67 M | - | 3.26 M | 1.71 M | 168 K | - | 100 K | 448 K | -119 K | - | 314 K | 216 K | 1.43 M | 477 K | 1.2 M | 524 K | 524 K | 1.63 M | 510 K | 736 K | 412 K | 118 K | 113 K | 96 K | 467 K | 92 K | 498 K | -340 K | -192 K | 379 K | 81 K | -95 K | 409 K | 287 K | 268 K | -142 K | 118 K | 164 K | 41 K | 42 K | -47 K | 26 K | 22 K | 74 K | 75 K | -158 K | 85.1 K | 79.6 K | 78.2 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.26 M | -340 K | 441 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
408 M | $ 20.1 | 1.85 % | $ 10.3 B | USA |
 |
ICU Medical
ICUI
|
107 M | $ 148.85 | -0.79 % | $ 3.63 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-1 K | $ 8.57 | 2.15 % | $ 173 M | USA |
 |
Alcon
ALC
|
192 M | $ 81.03 | -0.12 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
561 K | $ 5.39 | -1.1 % | $ 246 M | USA |
 |
AtriCure
ATRC
|
-326 K | $ 36.9 | -0.14 % | $ 1.73 B | USA |
 |
Haemonetics Corporation
HAE
|
-9.75 M | $ 66.55 | 0.88 % | $ 3.35 B | USA |
 |
electroCore
ECOR
|
6.3 M | $ 6.6 | -7.04 % | $ 36.4 K | USA |
 |
AngioDynamics
ANGO
|
4.94 M | $ 10.3 | 3.21 % | $ 421 M | USA |
 |
InfuSystem Holdings
INFU
|
1.4 M | $ 8.27 | 2.73 % | $ 171 M | USA |
 |
The Cooper Companies
COO
|
-16.4 M | $ 81.34 | 1.21 % | $ 16.2 B | USA |
 |
Masimo Corporation
MASI
|
300 K | $ 137.49 | 0.91 % | $ 7.33 B | USA |
 |
Harvard Bioscience
HBIO
|
-227 K | $ 0.5 | -6.73 % | $ 21.2 M | USA |
 |
Glaukos Corporation
GKOS
|
13.6 M | $ 119.29 | 0.28 % | $ 5.78 B | USA |
 |
Merit Medical Systems
MMSI
|
-711 K | $ 80.93 | 0.85 % | $ 4.71 B | USA |
 |
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
1.25 M | $ 154.21 | 3.5 % | $ 4.81 B | USA |
 |
LeMaitre Vascular
LMAT
|
205 K | $ 84.97 | 1.32 % | $ 1.91 B | USA |
 |
STERIS plc
STE
|
8.4 M | $ 261.9 | 0.02 % | $ 25.8 B | USA |
 |
Microbot Medical
MBOT
|
2 K | $ 1.81 | -2.96 % | $ 18.5 M |  Israel |
 |
Utah Medical Products
UTMD
|
256 K | $ 61.21 | -0.71 % | $ 222 M | USA |
 |
Nephros
NEPH
|
2 K | $ 4.35 | -0.91 % | $ 45.2 M | USA |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.29 | -2.67 % | $ 23.1 M | USA |
 |
Envista Holdings Corporation
NVST
|
-100 K | $ 23.4 | 0.13 % | $ 4.03 B | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 38.77 | -1.61 % | $ 127 M | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
983 K | $ 13.76 | 0.99 % | $ 661 M | USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 203.2 | 1.05 % | $ 58.5 B | USA |
 |
Repligen Corporation
RGEN
|
8.12 M | $ 150.44 | -3.8 % | $ 8.38 M | USA |
 |
ResMed
RMD
|
3.2 M | $ 256.15 | -0.57 % | $ 37.4 B | USA |
 |
BioLife Solutions
BLFS
|
497 K | $ 21.91 | -2.97 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
1.1 M | $ 2.21 | -5.36 % | $ 178 M | USA |
 |
Retractable Technologies
RVP
|
227 K | $ 0.7 | -1.03 % | $ 21 M | USA |
 |
STAAR Surgical Company
STAA
|
815 K | $ 18.9 | -0.24 % | $ 928 M | USA |
 |
Teleflex Incorporated
TFX
|
57 M | $ 104.44 | -0.96 % | $ 4.89 B | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 231.57 | -0.4 % | $ 16.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
12 M | $ 12.47 | 1.63 % | $ 2.53 B | USA |